Life
Developed low dose vaccine to prevent nCoV
CureVac can produce a billion doses of nCoV vaccine from existing facilities if the trial is successful.
Browse ScienceInfo articles and explainers related to MARN.
2 published items.
CureVac can produce a billion doses of nCoV vaccine from existing facilities if the trial is successful.
After humans die, some genes inside the body continue to function strongly for about two days.